Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: A community-based cohort study

Journal of the American College of Cardiology

Volumn 65, Issue 4, 2015, Pages 355-363

  Qi, Yue ^a   Fan, Jie ^a   Liu, Jing ^a   Wang, Wei ^a   Wang, Miao ^a   Sun, Jiayi ^a   Liu, Jun ^a   Xie, Wuxiang ^a   Zhao, Fan ^a   Li, Yan ^a   Zhao, Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

carotid atherosclerosis; cholesterol overloaded high density lipoprotein particle; high density lipoprotein cholesterol

Indexed keywords

CHOLESTEROL; CHOLESTEROL OVERLOADED HIGH DENSITY LIPOPROTEIN PARTICLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CAROTID ATHEROSCLEROSIS; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEALTH SURVEY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL PARTICLE RATIO; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; SMOKING; BLOOD; CAROTID ARTERY DISEASE; CHEMISTRY; ECHOGRAPHY; MIDDLE AGED;

AGED; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84921628667     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.11.019     Document Type: Article

References (32)

1. E. Di Angelantonio, N. Sarwar, and P. Perry Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
2. D. Keene, C. Price, M.J. Shun-Shin, and D.P. Francis Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients BMJ 349 2014 g4379
3. N. Kaur, A. Pandey, and H. Negi Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression PloS One 9 2014 e94585
4. K.K. Ray, J.J. Kastelein, and S. Matthijs Boekholdt The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011 Eur Heart J 35 2014 960 968
5. D.J. Rader, and A.R. Tall The not-so-simple HDL story: is it time to revise the HDL cholesterol hypothesis? Nat Med 18 2012 1344 1346
6. J.W. Heinecke The not-so-simple HDL story: a new era for quantifying HDL and cardiovascular risk? Nat Med 18 2012 1346 1347
7. R.S. Rosenson, H.B. Brewer Jr., and B. Ansell Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges Circulation 128 2013 1256 1267
8. A.V. Khera, M. Cuchel, and M. de la Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
9. H.C. Tan, E.S. Tai, and D. Sviridov Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus J Clin Lipidol 5 2011 467 473
10. S. Parish, A. Offer, and R. Clarke Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study Circulation 125 2012 2469 2478
11. S. Mora, R.J. Glynn, and P.M. Ridker High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy Circulation 128 2013 1189 1197
12. N. Rashedi, D. Brennan, J.J. Kastelein, S.E. Nissen, and S. Nicholls Impact of cholesteryl ester transfer protein inhibition on nuclear magnetic resonance derived lipoprotein particle parameters (abstr) Atherosclerosis Suppl 12 2011 48
13. T.F. Luscher, U. Landmesser, A. von Eckardstein, and A.M. Fogelman High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target Circ Res 114 2014 171 182
14. M. Vergeer, A.G. Holleboom, J.J. Kastelein, and J.A. Kuivenhoven The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 51 2010 2058 2073
15. S. Kunnen, and M. Van Eck Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J Lipid Res 53 2012 1783 1799
16. J.J. Albers, S. Vuletic, and M.C. Cheung Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism Biochim Biophysica Acta 1821 2012 345 357
17. J. Liu, W. Wang, and Y. Qi Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis J Atheroscler Thromb 21 2014 532 542
18. P.J. Touboul, M.G. Hennerici, and S. Meairs Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the Advisory Board of the 3rd, 4th and 5th Watching the Risk Symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011 Cerebrovasc Dis 34 2012 290 296
19. J. Fan, Y. Qi, and D. Zhao [A meta-analysis on the association between high-density lipoprotein particle subfractions and cardiovascular disease events] Zhong Hua Xin Xue Guan Bing Za Zhi 42 2014 57 61
20. M. Gomaraschi, A. Ossoli, and S. Pozzi eNOS activation by HDL is impaired in genetic CETP deficiency PloS One 9 2014 e95925
21. A.V. Khera, P.J. Patel, M.P. Reilly, and D.J. Rader The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality J Am Coll Cardiol 62 2013 1909 1910
22. P.H. Joshi, P.P. Toth, and S.T. Lirette Association of high-density lipoprotein subclasses and incident coronary heart disease: the Jackson Heart and Framingham Offspring Cohort Studies Eur J Prev Cardiol 2014 Jul 25 [E-pub ahead of print]
23. S.S. Martin, A.A. Khokhar, and H.T. May HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative Eur Heart J 2014 Jun 30 [E-pub ahead of print]
24. S.S. Martin, S.R. Jones, and P.P. Toth High-density lipoprotein subfractions: current views and clinical practice applications Trends Endocrinol Metab 25 2014 329 336
25. R.H. Mackey, P. Greenland, D.C. Goff Jr., D. Lloyd-Jones, C.T. Sibley, and S. Mora High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 60 2012 508 516
26. R. Gadi, A. Amanullah, and V.M. Figueredo HDL-C: does it matter? An update on novel HDL-directed pharmaco-therapeutic strategies I J Cardiol 167 2013 646 655
27. M.C. Phillips Molecular mechanisms of cellular cholesterol efflux J Biol Chem 289 2014 24020 24029
28. K.A. Rye, and P.J. Barter Cardioprotective functions of HDLs J Lipid Res 55 2014 168 179
29. D.S. Kim, A.A. Burt, and J.E. Ranchalis Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants Nutr Metab (Lond) 11 2014 44
30. Y. Huang, J.A. DiDonato, and B.S. Levison An abundant dysfunctional apolipoprotein A1 in human atheroma Nat Med 20 2014 193 203
31. S. Lee, K.G. Birukov, C.E. Romanoski, J.R. Springstead, A.J. Lusis, and J.A. Berliner Role of phospholipid oxidation products in atherosclerosis Circ Res 111 2012 778 799
32. M. de la Llera-Moya, D. Drazul-Schrader, B.F. Asztalos, M. Cuchel, D.J. Rader, and G.H. Rothblat The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages Arterioscler Thromb Vasc Biol 30 2010 796 801